SynthesisNephrology (Carlton, Vic.)2019
Haemoglobin variability and all-cause mortality in haemodialysis patients: A systematic review and meta-analysis.
Synthesis in Nephrology (Carlton, Vic.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 26 citations in OpenAlex.
- Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents in Patients with Anemia of Non-dialysis-Dependent or Incident-to-Dialysis Chronic Kidney Disease: Pooled Analysis of Four Phase 3 Studies.Advances in therapy · 2023Trial
- Six-Weekly Versus Monthly Haemodialysis Blood Testing in an Australian Tertiary Kidney Service: A Quality, Safety, Green Nephrology Initiative and Cost-Saving Analysis.Nephrology (Carlton, Vic.) · 2026Article
- Health-economic evaluation of a novel personalized digital avatar-based anemia management software in hemodialysis patients.NPJ digital medicine · 2026Article
- Comparison of hemoglobin variability between short- and intermediate-acting erythropoiesis-stimulating agents: a retrospective cohort study.Journal of Yeungnam medical science · 2026Article
- Dynamic hemoglobin trajectories and mortality in hemodialysis patients: a joint modeling study with iron and phosphorus markers.Frontiers in medicine · 2026Article
- Frequency of Routine Bloodwork Among Patients With Chronic Kidney Disease: A Narrative Review to Inform Appropriateness of Care.Canadian journal of kidney health and disease · 2026Review
- Hemoglobin stability impact on healthcare resource utilization and costs among dialysis-dependent patients with anemia of end-stage kidney disease.BMC nephrology · 2025Observational
- Effect of Erythropoiesis-Stimulating Agent Types on Hemoglobin Variability in Hemodialysis Patients.Journal of clinical medicine · 2025Article
- Article
- Erythropoiesis-stimulating agent responsiveness and hemoglobin variability is associated with fat tissue index in hemodialysis patients with darbepoetin-alfa treatment: a prospective observational cohort study.Kidney research and clinical practice · 2025Article
- Usage of the Anemia Control Model Is Associated with Reduced Hospitalization Risk in Hemodialysis.Biomedicines · 2024Article
- Effects of Individualized Anemia Therapy on Hemoglobin Stability: A Randomized Controlled Pilot Trial in Patients on Hemodialysis.Clinical journal of the American Society of Nephrology : CJASN · 2024Article
- Anemia biomarkers and mortality in hemodialysis patients with or without diabetes: A 10-year follow-up study.PloS one · 2023Article
- Low-Dose Oral Iron Replacement Therapy Is Effective for Many Japanese Hemodialysis Patients: A Retrospective Observational Study.Nutrients · 2022Observational
- Phase angle values, a good indicator of nutritional status, are associated with median value of hemoglobin rather than hemoglobin variability in hemodialysis patients.Renal failure · 2021Observational
- Effects of the route of erythropoietin administration on hemoglobin variability and cardiovascular events in hemodialysis patients.Kidney research and clinical practice · 2021Article
- Artificial intelligence supported anemia control system (AISACS) to prevent anemia in maintenance hemodialysis patients.International journal of medical sciences · 2021Article
- Is Hemoglobin Concentration a Linear Predictor of Mortality in Older Adults From Chinese Longevity Regions?Frontiers in public health · 2021Article
- Association between long-term hemoglobin variability and mortality in Korean adults: a nationwide population-based cohort study.Scientific reports · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimHaemoglobin (Hb) variability has been reported to be associated with mortality in dialysis patients in some but not all studies. We aimed to establish the prognostic significance of Hb variability with all-cause mortality in haemodialysis patients through this meta-analysis.
methodsThe Medline, Embase, Cochrane Library and Web of Science databases were searched for studies assessing the association between Hb variability and all-cause mortality in haemodialysis patients after adjustment for other covariates.
resultsWe included three studies of five cohorts with a total of 262 641 patients. Forest plots showed that the combined hazard ratio for all-cause mortality was 1.09 (95% CI = 1.01-1.08; P = 0.03) per 1 g/dL increase in Hb variability.
conclusionBased on the current evidence, our meta-analysis found an association between Hb variability and all-cause mortality in patients receiving haemodialysis therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.